513 related articles for article (PubMed ID: 25947967)
1. Lithium as a rescue therapy for regression and catatonia features in two SHANK3 patients with autism spectrum disorder: case reports.
Serret S; Thümmler S; Dor E; Vesperini S; Santos A; Askenazy F
BMC Psychiatry; 2015 May; 15():107. PubMed ID: 25947967
[TBL] [Abstract][Full Text] [Related]
2. Phelan-McDermid syndrome due to
Egger JIM; Verhoeven WMA; Groenendijk-Reijenga R; Kant SG
BMJ Case Rep; 2017 Sep; 2017():. PubMed ID: 28963116
[TBL] [Abstract][Full Text] [Related]
3. Delineation of the genetic and clinical spectrum of Phelan-McDermid syndrome caused by
De Rubeis S; Siper PM; Durkin A; Weissman J; Muratet F; Halpern D; Trelles MDP; Frank Y; Lozano R; Wang AT; Holder JL; Betancur C; Buxbaum JD; Kolevzon A
Mol Autism; 2018; 9():31. PubMed ID: 29719671
[TBL] [Abstract][Full Text] [Related]
4. A longitudinal perspective on the pharmacotherapy of 24 adult patients with Phelan McDermid syndrome.
Verhoeven WMA; Egger JIM; de Leeuw N
Eur J Med Genet; 2020 Mar; 63(3):103751. PubMed ID: 31465867
[TBL] [Abstract][Full Text] [Related]
5. A 29 Mainland Chinese cohort of patients with Phelan-McDermid syndrome: genotype-phenotype correlations and the role of SHANK3 haploinsufficiency in the important phenotypes.
Xu N; Lv H; Yang T; Du X; Sun Y; Xiao B; Fan Y; Luo X; Zhan Y; Wang L; Li F; Yu Y
Orphanet J Rare Dis; 2020 Nov; 15(1):335. PubMed ID: 33256793
[TBL] [Abstract][Full Text] [Related]
6. Psychiatric illness and regression in individuals with Phelan-McDermid syndrome.
Kohlenberg TM; Trelles MP; McLarney B; Betancur C; Thurm A; Kolevzon A
J Neurodev Disord; 2020 Feb; 12(1):7. PubMed ID: 32050889
[TBL] [Abstract][Full Text] [Related]
7. A Brazilian cohort of individuals with Phelan-McDermid syndrome: genotype-phenotype correlation and identification of an atypical case.
Samogy-Costa CI; Varella-Branco E; Monfardini F; Ferraz H; Fock RA; Barbosa RHA; Pessoa ALS; Perez ABA; Lourenço N; Vibranovski M; Krepischi A; Rosenberg C; Passos-Bueno MR
J Neurodev Disord; 2019 Jul; 11(1):13. PubMed ID: 31319798
[TBL] [Abstract][Full Text] [Related]
8. Phelan McDermid Syndrome: From Genetic Discoveries to Animal Models and Treatment.
Harony-Nicolas H; De Rubeis S; Kolevzon A; Buxbaum JD
J Child Neurol; 2015 Dec; 30(14):1861-70. PubMed ID: 26350728
[TBL] [Abstract][Full Text] [Related]
9. Interstitial 22q13 deletions not involving SHANK3 gene: a new contiguous gene syndrome.
Disciglio V; Lo Rizzo C; Mencarelli MA; Mucciolo M; Marozza A; Di Marco C; Massarelli A; Canocchi V; Baldassarri M; Ndoni E; Frullanti E; Amabile S; Anderlid BM; Metcalfe K; Le Caignec C; David A; Fryer A; Boute O; Joris A; Greco D; Pecile V; Battini R; Novelli A; Fichera M; Romano C; Mari F; Renieri A
Am J Med Genet A; 2014 Jul; 164A(7):1666-76. PubMed ID: 24700646
[TBL] [Abstract][Full Text] [Related]
10. Neurocognitive follow-up in adult siblings with Phelan-McDermid syndrome due to a novel SHANK3 splicing site mutation.
Kankuri-Tammilehto M; Sauna-Aho O; Arvio M
Mol Genet Genomic Med; 2021 Dec; 9(12):e1780. PubMed ID: 34369668
[TBL] [Abstract][Full Text] [Related]
11. A patient with the classic features of Phelan-McDermid syndrome and a high immunoglobulin E level caused by a cryptic interstitial 0.72-Mb deletion in the 22q13.2 region.
Simenson K; Õiglane-Shlik E; Teek R; Kuuse K; Õunap K
Am J Med Genet A; 2014 Mar; 164A(3):806-9. PubMed ID: 24375995
[TBL] [Abstract][Full Text] [Related]
12. A 22q13.33 duplication harbouring the SHANK3 gene: does it cause neuropsychiatric disorders?
Johannessen M; Haugen IB; Bakken TL; Braaten Ø
BMJ Case Rep; 2019 Nov; 12(11):. PubMed ID: 31678916
[TBL] [Abstract][Full Text] [Related]
13. The spectrum of epilepsy and electroencephalographic abnormalities due to SHANK3 loss-of-function mutations.
Holder JL; Quach MM
Epilepsia; 2016 Oct; 57(10):1651-1659. PubMed ID: 27554343
[TBL] [Abstract][Full Text] [Related]
14. Definition and clinical variability of SHANK3-related Phelan-McDermid syndrome.
Schön M; Lapunzina P; Nevado J; Mattina T; Gunnarsson C; Hadzsiev K; Verpelli C; Bourgeron T; Jesse S; van Ravenswaaij-Arts CMA; ; Hennekam RC
Eur J Med Genet; 2023 Jul; 66(7):104754. PubMed ID: 37003575
[TBL] [Abstract][Full Text] [Related]
15. Developmental social communication deficits in the Shank3 rat model of phelan-mcdermid syndrome and autism spectrum disorder.
Berg EL; Copping NA; Rivera JK; Pride MC; Careaga M; Bauman MD; Berman RF; Lein PJ; Harony-Nicolas H; Buxbaum JD; Ellegood J; Lerch JP; Wöhr M; Silverman JL
Autism Res; 2018 Apr; 11(4):587-601. PubMed ID: 29377611
[TBL] [Abstract][Full Text] [Related]
16. Neuropsychiatric decompensation in adolescents and adults with Phelan-McDermid syndrome: a systematic review of the literature.
Kolevzon A; Delaby E; Berry-Kravis E; Buxbaum JD; Betancur C
Mol Autism; 2019; 10():50. PubMed ID: 31879555
[TBL] [Abstract][Full Text] [Related]
17. A previously unrecognized 22q13.2 microdeletion syndrome that encompasses TCF20 and TNFRSF13C.
Upadia J; Gonzales PR; Atkinson TP; Schroeder HW; Robin NH; Rudy NL; Mikhail FM
Am J Med Genet A; 2018 Dec; 176(12):2791-2797. PubMed ID: 30216695
[TBL] [Abstract][Full Text] [Related]
18. 22q13 deletion syndrome: communication disorder or autism? Evidence from a specific clinical and neurophysiological phenotype.
Ponson L; Gomot M; Blanc R; Barthelemy C; Roux S; Munnich A; Romana S; Aguillon-Hernandez N; Malan V; Bonnet-Brilhault F
Transl Psychiatry; 2018 Aug; 8(1):146. PubMed ID: 30089781
[TBL] [Abstract][Full Text] [Related]
19. Behavioral Phenotyping of an Improved Mouse Model of Phelan-McDermid Syndrome with a Complete Deletion of the
Drapeau E; Riad M; Kajiwara Y; Buxbaum JD
eNeuro; 2018; 5(3):. PubMed ID: 30302388
[TBL] [Abstract][Full Text] [Related]
20. Case report: an unexpected link between partial deletion of the SHANK3 gene and Heller's dementia infantilis, a rare subtype of autism spectrum disorder.
Philippe A; Craus Y; Rio M; Bahi-Buisson N; Boddaert N; Malan V; Bonnefont JP; Robel L
BMC Psychiatry; 2015 Oct; 15():256. PubMed ID: 26489495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
